Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Value of PK-Adjusted Phenotypic Susceptibility in HIV
NCT00027339Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of indinavir, fosamprenavir, lopinavir in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
indinavirfosamprenavirlopinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00027339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027339.